Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Travera Inc
Travera Inc
University of Oklahoma
Eastern Cooperative Oncology Group
Institut du Cancer de Montpellier - Val d'Aurelle
Silverback Therapeutics
NKGen Biotech, Inc.
Institut de Cancérologie de la Loire
SWOG Cancer Research Network
Alliance for Clinical Trials in Oncology